NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

It's a matter of negotiation. First and foremost, how good is the news and how certain? If some deal is pending and that's the news then the terms of the deal are very material. Otherwise from where I sit the only certainly highly valuable news is MAA approval. At that point certainly it's possible for the company to produce credible projections of market penetration, growth rate, revenues and profits. You know, the normal things that drive valuations of companies that are beyond the purely speculative phase.

Short of that it's a matter of how much the buyer wants to buy in and subject to negotiations. The stock having gotten smashed down every time it's extended could make agreeing on a fair price difficult, that is for sure. As you well understand. I don't know why you are even asking this question as the above is very obvious.